Skip to main content
Top
Published in: Current Psychiatry Reports 12/2013

01-12-2013 | Sleep Disorders (RM Benca, Section Editor)

Insomnia and its Impact on Physical and Mental Health

Authors: Julio Fernandez-Mendoza, Alexandros N. Vgontzas

Published in: Current Psychiatry Reports | Issue 12/2013

Login to get access

Abstract

In contrast to the association of insomnia with mental health, its association with physical health has remained largely unexplored until recently. Based on findings that insomnia with objective short sleep duration is associated with activation of both limbs of the stress system and other indices of physiological hyperarousal, which should adversely affect physical and mental health, we have recently demonstrated that this insomnia phenotype is associated with a significant risk of cardiometabolic and neurocognitive morbidity and mortality. In contrast, insomnia with normal sleep duration is associated with sleep misperception and cognitive-emotional arousal, but not with signs of physiological hyperarousal or cardiometabolic or neurocognitive morbidity. Interestingly, both insomnia phenotypes are associated with mental health, although most likely through different pathophysiological mechanisms. We propose that objective measures of sleep duration may become part of the routine evaluation and diagnosis of insomnia, and that these two insomnia phenotypes may respond differentially to biological versus psychological treatments.
Literature
1.
go back to reference Bixler EO, Vgontzas AN, Lin HM, Vela-Bueno A, Kales A. Insomnia in central Pennsylvania. J Psychosom Res. 2002;53:589–92.PubMedCrossRef Bixler EO, Vgontzas AN, Lin HM, Vela-Bueno A, Kales A. Insomnia in central Pennsylvania. J Psychosom Res. 2002;53:589–92.PubMedCrossRef
2.
go back to reference Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6:97–111.PubMedCrossRef Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6:97–111.PubMedCrossRef
3.
go back to reference Chong Y, Fryar CD, Gu Q. Prescription sleep aid use among adults: United States, 2005–2010. NCHS data brief, no 127. Hyattsville, MD: National Center for Health Statistics; 2013. Chong Y, Fryar CD, Gu Q. Prescription sleep aid use among adults: United States, 2005–2010. NCHS data brief, no 127. Hyattsville, MD: National Center for Health Statistics; 2013.
4.
go back to reference Reynolds 3rd CF, Kupfer DJ, Buysse DJ, Coble PA, Yeager A. Subtyping DSM-III-R primary insomnia: a literature review by the DSM-IV Work Group on Sleep Disorders. Am J Psychiatry. 1991;148:432–8.PubMed Reynolds 3rd CF, Kupfer DJ, Buysse DJ, Coble PA, Yeager A. Subtyping DSM-III-R primary insomnia: a literature review by the DSM-IV Work Group on Sleep Disorders. Am J Psychiatry. 1991;148:432–8.PubMed
5.
go back to reference American Psychiatric Association. Diagnostic and statistical manual of mental disorders, text revision. 4th ed. Washington, DC: American Psychiatric Association; 2000. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, text revision. 4th ed. Washington, DC: American Psychiatric Association; 2000.
6.
go back to reference American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Press; 2013. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Press; 2013.
7.
go back to reference American Academy of Sleep Medicine. The International Classification of Sleep Disorders (ICSD-2): diagnostic and coding manual. 2nd ed. Westchester: American Academy of Sleep Medicine; 2005. American Academy of Sleep Medicine. The International Classification of Sleep Disorders (ICSD-2): diagnostic and coding manual. 2nd ed. Westchester: American Academy of Sleep Medicine; 2005.
8.••
go back to reference Edinger JD, Wyatt JK, Stepanski EJ, Olsen MK, Stechuchak KM, Carney CE, et al. Testing the reliability and validity of DSM-IV-TR and ICSD-2 insomnia diagnoses. Results of a multitrait-multimethod analysis. Arch Gen Psychiatry. 2011;68:992–1002. This multi-site study found that current insomnia nosologies have low validity.PubMedCrossRef Edinger JD, Wyatt JK, Stepanski EJ, Olsen MK, Stechuchak KM, Carney CE, et al. Testing the reliability and validity of DSM-IV-TR and ICSD-2 insomnia diagnoses. Results of a multitrait-multimethod analysis. Arch Gen Psychiatry. 2011;68:992–1002. This multi-site study found that current insomnia nosologies have low validity.PubMedCrossRef
10.
go back to reference Vgontzas AN, Bixler EO, Kales A, Criley C, Vela-Bueno A. Differences in nocturnal and daytime sleep between primary and psychiatric hypersomnia: diagnostic and treatment implications. Psychosom Med. 2000;62:220–6.PubMed Vgontzas AN, Bixler EO, Kales A, Criley C, Vela-Bueno A. Differences in nocturnal and daytime sleep between primary and psychiatric hypersomnia: diagnostic and treatment implications. Psychosom Med. 2000;62:220–6.PubMed
11.
go back to reference Vgontzas AN, Bixler EO, Kales A, Manfredi RL, Tyson K. Validity and clinical utility of sleep laboratory criteria for insomnia. Int J Neurosci. 1994;77:11–21.PubMedCrossRef Vgontzas AN, Bixler EO, Kales A, Manfredi RL, Tyson K. Validity and clinical utility of sleep laboratory criteria for insomnia. Int J Neurosci. 1994;77:11–21.PubMedCrossRef
12.
go back to reference Vgontzas AN, Kales A, Bixler EO, Manfredi RL, Vela-Bueno A. Usefulness of polysomnographic studies in the differential diagnosis of insomnia. Int J Neurosci. 1995;82:47–60.PubMedCrossRef Vgontzas AN, Kales A, Bixler EO, Manfredi RL, Vela-Bueno A. Usefulness of polysomnographic studies in the differential diagnosis of insomnia. Int J Neurosci. 1995;82:47–60.PubMedCrossRef
13.
go back to reference Littner M, Hirshkowitz M, Kramer M, Kapen S, Anderson WM, Bailey D, et al. Practice parameters for using polysomnography to evaluate insomnia: an update. Sleep. 2003;26:754–60.PubMed Littner M, Hirshkowitz M, Kramer M, Kapen S, Anderson WM, Bailey D, et al. Practice parameters for using polysomnography to evaluate insomnia: an update. Sleep. 2003;26:754–60.PubMed
14.
go back to reference Kales A, Kales JD. Evaluation and treatment of insomnia. New York: Oxford University Press; 1984. Kales A, Kales JD. Evaluation and treatment of insomnia. New York: Oxford University Press; 1984.
15.
go back to reference LeBlanc M, Beaulieu-Bonneau S, Merette C, Savard J, Ivers H, Morin CM. Psychological and health-related quality of life factors associated with insomnia in a population-based sample. J Psychosom Res. 2007;63:157–66.PubMedCrossRef LeBlanc M, Beaulieu-Bonneau S, Merette C, Savard J, Ivers H, Morin CM. Psychological and health-related quality of life factors associated with insomnia in a population-based sample. J Psychosom Res. 2007;63:157–66.PubMedCrossRef
16.
go back to reference Morin CM, Rodrigue S, Ivers H. Role of stress, arousal, and coping skills in primary insomnia. Psychosom Med. 2003;65:259–67.PubMedCrossRef Morin CM, Rodrigue S, Ivers H. Role of stress, arousal, and coping skills in primary insomnia. Psychosom Med. 2003;65:259–67.PubMedCrossRef
17.
go back to reference LeBlanc M, Mérette C, Savard J, Ivers H, Baillargeon L, Morin CM. Incidence and risk factors of insomnia in a population-based sample. Sleep. 2009;32:1027–37.PubMed LeBlanc M, Mérette C, Savard J, Ivers H, Baillargeon L, Morin CM. Incidence and risk factors of insomnia in a population-based sample. Sleep. 2009;32:1027–37.PubMed
18.
go back to reference Fernández-Mendoza J, Vela-Bueno A, Vgontzas AN, Ramos-Platón MJ, Olavarrieta-Bernardino S, Bixler EO, et al. Cognitive-emotional hyperarousal as a premorbid characteristic of individuals vulnerable to insomnia. Psychosom Med. 2010;72:397–403.PubMedCrossRef Fernández-Mendoza J, Vela-Bueno A, Vgontzas AN, Ramos-Platón MJ, Olavarrieta-Bernardino S, Bixler EO, et al. Cognitive-emotional hyperarousal as a premorbid characteristic of individuals vulnerable to insomnia. Psychosom Med. 2010;72:397–403.PubMedCrossRef
19.
go back to reference Singareddy R, Vgontzas AN, Fernandez-Mendoza J, Liao D, Calhoun S, Shaffer ML, et al. Risk factors for incident chronic insomnia: a general population prospective study. Sleep Med. 2012;13:346–53.PubMedCrossRef Singareddy R, Vgontzas AN, Fernandez-Mendoza J, Liao D, Calhoun S, Shaffer ML, et al. Risk factors for incident chronic insomnia: a general population prospective study. Sleep Med. 2012;13:346–53.PubMedCrossRef
20.••
go back to reference Fernandez-Mendoza J, Vgontzas AN, Bixler EO, Singareddy R, Shaffer ML, Calhoun SL, et al. Clinical and polysomnographic predictors of the natural history of poor sleep in the general population. Sleep. 2012;35:689–97. This prospective cohort study found that objective short sleep duration, mental health problems, and familial history of insomnia predict incident insomnia in poor sleepers.PubMed Fernandez-Mendoza J, Vgontzas AN, Bixler EO, Singareddy R, Shaffer ML, Calhoun SL, et al. Clinical and polysomnographic predictors of the natural history of poor sleep in the general population. Sleep. 2012;35:689–97. This prospective cohort study found that objective short sleep duration, mental health problems, and familial history of insomnia predict incident insomnia in poor sleepers.PubMed
21.
go back to reference Healey ES, Kales A, Monroe LJ, Bixler EO, Chamberlin K, Soldatos CR. Onset of insomnia: role of life-stress events. Psychosom Med. 1981;43:439–51.PubMed Healey ES, Kales A, Monroe LJ, Bixler EO, Chamberlin K, Soldatos CR. Onset of insomnia: role of life-stress events. Psychosom Med. 1981;43:439–51.PubMed
22.
go back to reference Monroe LJ. Psychological and physiological differences between good and poor sleepers. J Abnorm Psychol. 1967;72:255–64.PubMedCrossRef Monroe LJ. Psychological and physiological differences between good and poor sleepers. J Abnorm Psychol. 1967;72:255–64.PubMedCrossRef
23.
go back to reference Johns MW, Gay TJA, Masterton JP, Bruce DW. Relationship between habits, adrenocortical activity and personality. Psychosom Med. 1971;33:499–508.PubMed Johns MW, Gay TJA, Masterton JP, Bruce DW. Relationship between habits, adrenocortical activity and personality. Psychosom Med. 1971;33:499–508.PubMed
24.
go back to reference Frankel BL, Buchbinder R, Coursey R, Snyder F. Sleep patterns and psychological test characteristics of chronic primary insomniacs. Sleep Res. 1973;2:149. Frankel BL, Buchbinder R, Coursey R, Snyder F. Sleep patterns and psychological test characteristics of chronic primary insomniacs. Sleep Res. 1973;2:149.
25.
go back to reference Adam K, Tomeny M, Oswald I. Physiological and psychological differences between good and poor sleepers. J Psychiatr Res. 1986;20:301–16.PubMedCrossRef Adam K, Tomeny M, Oswald I. Physiological and psychological differences between good and poor sleepers. J Psychiatr Res. 1986;20:301–16.PubMedCrossRef
26.
go back to reference Vgontzas AN, Tsigos C, Bixler EO, Stratakis CA, Zachman K, Kales A, et al. Chronic insomnia and activity of the stress system: a preliminary study. J Psychosom Res. 1998;45:21–31.PubMedCrossRef Vgontzas AN, Tsigos C, Bixler EO, Stratakis CA, Zachman K, Kales A, et al. Chronic insomnia and activity of the stress system: a preliminary study. J Psychosom Res. 1998;45:21–31.PubMedCrossRef
27.
go back to reference Vgontzas AN, Bixler EO, Lin HM, Prolo P, Mastorakos G, Vela-Bueno A, et al. Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab. 2001;86:3787–94.PubMedCrossRef Vgontzas AN, Bixler EO, Lin HM, Prolo P, Mastorakos G, Vela-Bueno A, et al. Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab. 2001;86:3787–94.PubMedCrossRef
28.
go back to reference Rodenbeck A, Huether G, Ruether E, Hajak G. Interactions between evening and nocturnal cortisol secretion and sleep parameters in patients with severe chronic primary insomnia. Neurosci Lett. 2002;324:159–63.PubMedCrossRef Rodenbeck A, Huether G, Ruether E, Hajak G. Interactions between evening and nocturnal cortisol secretion and sleep parameters in patients with severe chronic primary insomnia. Neurosci Lett. 2002;324:159–63.PubMedCrossRef
29.
go back to reference Shaver JL, Johnston SK, Lentz MJ, Landis CA. Stress exposure, psychological distress, and physiological stress activation in midlife women with insomnia. Psychosom Med. 2002;64:793–802.PubMedCrossRef Shaver JL, Johnston SK, Lentz MJ, Landis CA. Stress exposure, psychological distress, and physiological stress activation in midlife women with insomnia. Psychosom Med. 2002;64:793–802.PubMedCrossRef
30.
go back to reference Rodenbeck A, Cohrs S, Jordan W, Huether G, Rüther E, Hajak G. The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia. A placebo-controlled, double-blind, randomized, cross-over study followed by an open treatment over 3 weeks. Psychopharmacology (Berl). 2003;170:423–8.PubMedCrossRef Rodenbeck A, Cohrs S, Jordan W, Huether G, Rüther E, Hajak G. The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia. A placebo-controlled, double-blind, randomized, cross-over study followed by an open treatment over 3 weeks. Psychopharmacology (Berl). 2003;170:423–8.PubMedCrossRef
31.
go back to reference Irwin M, Clark C, Kennedy B, Christian Gillin J, Ziegler M. Nocturnal catecholamines and immune function in insomniacs, depressed patients, and controls subjects. Brain Behav Immun. 2003;17:365–72.PubMedCrossRef Irwin M, Clark C, Kennedy B, Christian Gillin J, Ziegler M. Nocturnal catecholamines and immune function in insomniacs, depressed patients, and controls subjects. Brain Behav Immun. 2003;17:365–72.PubMedCrossRef
32.
go back to reference Riemann D, Klein T, Rodenbeck A, Feige B, Horney A, Hummel R, et al. Nocturnal cortisol and melatonin secretion in primary insomnia. Psychiatry Res. 2002;113:17–27.PubMedCrossRef Riemann D, Klein T, Rodenbeck A, Feige B, Horney A, Hummel R, et al. Nocturnal cortisol and melatonin secretion in primary insomnia. Psychiatry Res. 2002;113:17–27.PubMedCrossRef
33.
go back to reference Varkevisser M, Van Dongen HP, Kerkhof GA. Physiologic indexes in chronic insomnia during a constant routine: evidence for general hyperarousal? Sleep. 2005;28:1588–96.PubMed Varkevisser M, Van Dongen HP, Kerkhof GA. Physiologic indexes in chronic insomnia during a constant routine: evidence for general hyperarousal? Sleep. 2005;28:1588–96.PubMed
34.
go back to reference Bonnet MH. Hyperarousal as the basis for insomnia: effect size and significance. Sleep. 2005;28:1500–1.PubMed Bonnet MH. Hyperarousal as the basis for insomnia: effect size and significance. Sleep. 2005;28:1500–1.PubMed
35.
go back to reference Vgontzas AN, Bixler EO, Wittman AM, Zachman K, Lin HM, Vela-Bueno A, et al. Middle-aged men show higher sensitivity of sleep to the arousing effects of corticotropin-releasing hormone than young men: clinical implications. J Clin Endocrinol Metab. 2001;86:1489–95.PubMedCrossRef Vgontzas AN, Bixler EO, Wittman AM, Zachman K, Lin HM, Vela-Bueno A, et al. Middle-aged men show higher sensitivity of sleep to the arousing effects of corticotropin-releasing hormone than young men: clinical implications. J Clin Endocrinol Metab. 2001;86:1489–95.PubMedCrossRef
36.
go back to reference Stepanski E, Glinn M, Zorick F, Roehrs T, Roth T. Heart rate changes in chronic insomnia. Stress Med. 1994;10:261–6.CrossRef Stepanski E, Glinn M, Zorick F, Roehrs T, Roth T. Heart rate changes in chronic insomnia. Stress Med. 1994;10:261–6.CrossRef
37.
go back to reference Bonnet MH, Arand DL. Heart rate variability in insomniacs and matched normal sleepers. Psychosom Med. 1998;60:610–5.PubMed Bonnet MH, Arand DL. Heart rate variability in insomniacs and matched normal sleepers. Psychosom Med. 1998;60:610–5.PubMed
38.
go back to reference Bonnet MH, Arand DL. 24-hour metabolic rate in insomniacs and matched normal sleepers. Sleep. 1995;18:581–8.PubMed Bonnet MH, Arand DL. 24-hour metabolic rate in insomniacs and matched normal sleepers. Sleep. 1995;18:581–8.PubMed
39.
go back to reference Bonnet MH, Arand DL. Physiological activation in patients with sleep state misperception. Psychosom Med. 1997;59:533–40.PubMed Bonnet MH, Arand DL. Physiological activation in patients with sleep state misperception. Psychosom Med. 1997;59:533–40.PubMed
40.
go back to reference Lichstein K, Johnson RS. Pupillometric discrimination of insomniacs. Behav Res Ther. 1994;32:123–9.PubMedCrossRef Lichstein K, Johnson RS. Pupillometric discrimination of insomniacs. Behav Res Ther. 1994;32:123–9.PubMedCrossRef
41.
go back to reference Lichstein KL, Johnson RS, Sen Gupta S, O’Laughlin DL, Dykstra TA. Are insomniacs sleepy during the day? A pupillometric assessment. Behav Res Ther. 1992;30:283–92.PubMedCrossRef Lichstein KL, Johnson RS, Sen Gupta S, O’Laughlin DL, Dykstra TA. Are insomniacs sleepy during the day? A pupillometric assessment. Behav Res Ther. 1992;30:283–92.PubMedCrossRef
42.
go back to reference Lichstein KL, Wilson NM, Noe SL, Aguillard RN, Bellur SN. Daytime sleepiness in insomnia: behavioral, biological and subjective indices. Sleep. 1994;17:693–702.PubMed Lichstein KL, Wilson NM, Noe SL, Aguillard RN, Bellur SN. Daytime sleepiness in insomnia: behavioral, biological and subjective indices. Sleep. 1994;17:693–702.PubMed
43.
go back to reference Seidel WF, Ball S, Cohen S, Patterson N, Yost D, Dement WC. Daytime alertness in relation to mood, performance, and nocturnal sleep in chronic insomniacs and noncomplaining sleepers. Sleep. 1984;7:230–8.PubMed Seidel WF, Ball S, Cohen S, Patterson N, Yost D, Dement WC. Daytime alertness in relation to mood, performance, and nocturnal sleep in chronic insomniacs and noncomplaining sleepers. Sleep. 1984;7:230–8.PubMed
44.
go back to reference Stepanski E, Zorick F, Roehrs T, Young D, Roth T. Daytime alertness in patients with chronic insomnia compared with asymptomatic control subjects. Sleep. 1988;11:54–60.PubMed Stepanski E, Zorick F, Roehrs T, Young D, Roth T. Daytime alertness in patients with chronic insomnia compared with asymptomatic control subjects. Sleep. 1988;11:54–60.PubMed
45.
go back to reference Bonnet MH, Arand DL. Activity, arousal, and the MSLT in patients with insomnia. Sleep. 2000;23:205–12.PubMed Bonnet MH, Arand DL. Activity, arousal, and the MSLT in patients with insomnia. Sleep. 2000;23:205–12.PubMed
46.
go back to reference Sugerman JL, Stern JA, Walsh JK. Daytime alertness in subjective and objective insomnia: some preliminary findings. Biol Psychiatry. 1985;20:741–50.PubMedCrossRef Sugerman JL, Stern JA, Walsh JK. Daytime alertness in subjective and objective insomnia: some preliminary findings. Biol Psychiatry. 1985;20:741–50.PubMedCrossRef
47.
go back to reference Dorsey CM, Bootzin RR. Subjective and psychophysiologic insomnia: an examination of sleep tendency and personality. Biol Psychiatry. 1997;41:209–16.PubMedCrossRef Dorsey CM, Bootzin RR. Subjective and psychophysiologic insomnia: an examination of sleep tendency and personality. Biol Psychiatry. 1997;41:209–16.PubMedCrossRef
48.
go back to reference Roehrs TA, Randall S, Harris E, Maan R, Roth T. MSLT in primary insomnia: stability and relation to nocturnal sleep. Sleep. 2011;34:1647–52.PubMed Roehrs TA, Randall S, Harris E, Maan R, Roth T. MSLT in primary insomnia: stability and relation to nocturnal sleep. Sleep. 2011;34:1647–52.PubMed
49.
go back to reference Bonnet MH, Arand DL. Clinical effects of sleep fragmentation versus sleep deprivation. Sleep Med Rev. 2003;7:297–310.PubMedCrossRef Bonnet MH, Arand DL. Clinical effects of sleep fragmentation versus sleep deprivation. Sleep Med Rev. 2003;7:297–310.PubMedCrossRef
50.
go back to reference Vgontzas AN, Zoumakis E, Bixler EO, Lin HM, Follett H, Kales A, et al. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab. 2004;89:2119–26.PubMedCrossRef Vgontzas AN, Zoumakis E, Bixler EO, Lin HM, Follett H, Kales A, et al. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab. 2004;89:2119–26.PubMedCrossRef
51.
go back to reference Nofzinger EA, Nissen C, Germain A, Moul D, Hall M, Price JC, et al. Regional cerebral metabolic correlates of WASO during NREM sleep in insomnia. J Clin Sleep Med. 2006;2:316–22.PubMed Nofzinger EA, Nissen C, Germain A, Moul D, Hall M, Price JC, et al. Regional cerebral metabolic correlates of WASO during NREM sleep in insomnia. J Clin Sleep Med. 2006;2:316–22.PubMed
52.
go back to reference Winkelman JW, Buxton OM, Jensen JE, Benson KL, O’Connor SP, Wang W, et al. Reduced brain GABA in primary insomnia: preliminary data from 4T proton magnetic resonance spectroscopy (1H-MRS). Sleep. 2008;311:1499–506. Winkelman JW, Buxton OM, Jensen JE, Benson KL, O’Connor SP, Wang W, et al. Reduced brain GABA in primary insomnia: preliminary data from 4T proton magnetic resonance spectroscopy (1H-MRS). Sleep. 2008;311:1499–506.
53.
go back to reference Krystal AD, Edinger JD, Wohlgemuth WK, Marsh GR. NREM sleep EEG frequency spectral correlates of sleep complaints in primary insomnia subtypes. Sleep. 2002;25:630–40.PubMed Krystal AD, Edinger JD, Wohlgemuth WK, Marsh GR. NREM sleep EEG frequency spectral correlates of sleep complaints in primary insomnia subtypes. Sleep. 2002;25:630–40.PubMed
54.
go back to reference Corsi-Cabrera M, Figueredo-Rodríguez P, del Río-Portilla Y, Sánchez-Romero J, Galán L, Bosch-Bayard J. Enhanced frontoparietal synchronized activation during the wake-sleep transition in patients with primary insomnia. Sleep. 2012;35:501–11.PubMed Corsi-Cabrera M, Figueredo-Rodríguez P, del Río-Portilla Y, Sánchez-Romero J, Galán L, Bosch-Bayard J. Enhanced frontoparietal synchronized activation during the wake-sleep transition in patients with primary insomnia. Sleep. 2012;35:501–11.PubMed
55.
go back to reference Parrino L, Milioli G, De Paolis F, Grassi A, Terzano MG. Paradoxical insomnia: the role of CAP and arousals in sleep misperception. Sleep Med. 2009;10:1139–45.PubMedCrossRef Parrino L, Milioli G, De Paolis F, Grassi A, Terzano MG. Paradoxical insomnia: the role of CAP and arousals in sleep misperception. Sleep Med. 2009;10:1139–45.PubMedCrossRef
56.
go back to reference Bastien CH, Turcotte I, St-Jean G, Morin CM, Carrier J. Information processing varies between insomnia types: measures of N1 and P2 during the night. Behav Sleep Med. 2013;11:56–72.PubMedCrossRef Bastien CH, Turcotte I, St-Jean G, Morin CM, Carrier J. Information processing varies between insomnia types: measures of N1 and P2 during the night. Behav Sleep Med. 2013;11:56–72.PubMedCrossRef
57.
go back to reference Cano G, Mochizuki T, Saper CB. Neural circuitry of stress-induced insomnia in rats. J Neurosci. 2008;28:10167–84.PubMedCrossRef Cano G, Mochizuki T, Saper CB. Neural circuitry of stress-induced insomnia in rats. J Neurosci. 2008;28:10167–84.PubMedCrossRef
58.
go back to reference Fernandez-Mendoza J, Calhoun SL, Bixler EO, Karataraki M, Liao D, Vela-Bueno A, et al. Sleep misperception and chronic insomnia in the general population: role of objective sleep duration and psychological profiles. Psychosom Med. 2011;73:88–97.PubMedCrossRef Fernandez-Mendoza J, Calhoun SL, Bixler EO, Karataraki M, Liao D, Vela-Bueno A, et al. Sleep misperception and chronic insomnia in the general population: role of objective sleep duration and psychological profiles. Psychosom Med. 2011;73:88–97.PubMedCrossRef
59.••
go back to reference Vgontzas AN, Fernandez-Mendoza J, Liao D, Bixler EO. Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder. Sleep Med Rev. 2013;17:241–54. This article comprehensively reviews the association of insomnia with objective short sleep duration with physiological hyperarousal, medical morbidity, and mortality.PubMedCrossRef Vgontzas AN, Fernandez-Mendoza J, Liao D, Bixler EO. Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder. Sleep Med Rev. 2013;17:241–54. This article comprehensively reviews the association of insomnia with objective short sleep duration with physiological hyperarousal, medical morbidity, and mortality.PubMedCrossRef
60.
go back to reference Bonnet MH, Arand DL. Cardiovascular implications of poor sleep. Sleep Med Clin. 2007;2:529–38.CrossRef Bonnet MH, Arand DL. Cardiovascular implications of poor sleep. Sleep Med Clin. 2007;2:529–38.CrossRef
61.
go back to reference Suka M, Yoshida K, Sugimori H. Persistent insomnia is a predictor of hypertension in Japanese male workers. J Occup Health. 2003;45:344–50.PubMedCrossRef Suka M, Yoshida K, Sugimori H. Persistent insomnia is a predictor of hypertension in Japanese male workers. J Occup Health. 2003;45:344–50.PubMedCrossRef
62.
go back to reference Laugsand LE, Vatten LJ, Platou C, Janszky I. Insomnia and the risk of acute myocardial infarction: a population study. Circulation. 2011;124:2073–81.PubMedCrossRef Laugsand LE, Vatten LJ, Platou C, Janszky I. Insomnia and the risk of acute myocardial infarction: a population study. Circulation. 2011;124:2073–81.PubMedCrossRef
63.
go back to reference Kawakami N, Takatsuka N, Shimizu H. Sleep disturbance and onset of type 2 diabetes. Diabetes Care. 2004;27:282–3.PubMedCrossRef Kawakami N, Takatsuka N, Shimizu H. Sleep disturbance and onset of type 2 diabetes. Diabetes Care. 2004;27:282–3.PubMedCrossRef
64.
go back to reference Nilsson PM, Rööst M, Engström G, Hedblad B, Berglund G. Incidence of diabetes in middle-aged men is related to sleep disturbances. Diabetes Care. 2004;27:2464–9.PubMedCrossRef Nilsson PM, Rööst M, Engström G, Hedblad B, Berglund G. Incidence of diabetes in middle-aged men is related to sleep disturbances. Diabetes Care. 2004;27:2464–9.PubMedCrossRef
65.
go back to reference Meisinger C, Heier M, Loewel H, MONICA/KORA Augsburg Cohort Study. Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population. Diabetologia. 2005;48:235–41.PubMedCrossRef Meisinger C, Heier M, Loewel H, MONICA/KORA Augsburg Cohort Study. Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population. Diabetologia. 2005;48:235–41.PubMedCrossRef
66.
go back to reference Mallon L, Broman JE, Hetta J. High incidence of diabetes in men with sleep complaints or short sleep duration: a 12-year follow-up study of a middle-aged population. Diabetes Care. 2005;28:2762–7.PubMedCrossRef Mallon L, Broman JE, Hetta J. High incidence of diabetes in men with sleep complaints or short sleep duration: a 12-year follow-up study of a middle-aged population. Diabetes Care. 2005;28:2762–7.PubMedCrossRef
67.
go back to reference Phillips B, Mannino DM. Do insomnia complaints cause hypertension or cardiovascular disease? J Clin Sleep Med. 2007;3:489–94.PubMed Phillips B, Mannino DM. Do insomnia complaints cause hypertension or cardiovascular disease? J Clin Sleep Med. 2007;3:489–94.PubMed
68.
go back to reference Bonnet MH. Evidence for the pathophysiology of insomnia. Sleep. 2009;32:441–2.PubMed Bonnet MH. Evidence for the pathophysiology of insomnia. Sleep. 2009;32:441–2.PubMed
69.
go back to reference Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry. 2002;59:131–6.PubMedCrossRef Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry. 2002;59:131–6.PubMedCrossRef
70.••
go back to reference Vgontzas AN, Liao D, Bixler EO, Chrousos GP, Vela-Bueno A. Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep. 2009;32:491–7. This was the first cohort study to show an association of insomnia with objective short sleep duration with significant medical morbidity, that is, hypertension.PubMed Vgontzas AN, Liao D, Bixler EO, Chrousos GP, Vela-Bueno A. Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep. 2009;32:491–7. This was the first cohort study to show an association of insomnia with objective short sleep duration with significant medical morbidity, that is, hypertension.PubMed
71.••
go back to reference Fernandez-Mendoza J, Vgontzas AN, Liao D, Shaffer ML, Vela-Bueno A, Basta M, et al. Insomnia with objective short sleep duration and incident hypertension: the Penn State Cohort. Hypertension. 2012;60:929–35. This prospective cohort study confirmed the longitudinal association of insomnia with objective short sleep duration with hypertension.PubMedCrossRef Fernandez-Mendoza J, Vgontzas AN, Liao D, Shaffer ML, Vela-Bueno A, Basta M, et al. Insomnia with objective short sleep duration and incident hypertension: the Penn State Cohort. Hypertension. 2012;60:929–35. This prospective cohort study confirmed the longitudinal association of insomnia with objective short sleep duration with hypertension.PubMedCrossRef
72.••
go back to reference Vgontzas AN, Liao D, Pejovic S, Calhoun S, Karataraki M, Bixler EO. Insomnia with objective short sleep duration is associated with type 2 diabetes: A population-based study. Diabetes Care. 2009;32:1980–5. This cohort study showed an association of insomnia with objective short sleep duration with increased risk of diabetes.PubMedCrossRef Vgontzas AN, Liao D, Pejovic S, Calhoun S, Karataraki M, Bixler EO. Insomnia with objective short sleep duration is associated with type 2 diabetes: A population-based study. Diabetes Care. 2009;32:1980–5. This cohort study showed an association of insomnia with objective short sleep duration with increased risk of diabetes.PubMedCrossRef
73.
go back to reference Vgontzas AN, Liao D, Pejovic S, Calhoun S, Karataraki M, Basta M, et al. Insomnia with short sleep duration and mortality: the Penn State cohort. Sleep. 2010;33:1159–64.PubMed Vgontzas AN, Liao D, Pejovic S, Calhoun S, Karataraki M, Basta M, et al. Insomnia with short sleep duration and mortality: the Penn State cohort. Sleep. 2010;33:1159–64.PubMed
74.
go back to reference Vgontzas AN, Fernandez-Mendoza J, Miksiewicz T, Kritikou I, Shaffer ML, Liao D, et al. Unveiling the longitudinal association between short sleep duration and the incidence of obesity: the Penn State cohort. Int J Obes (Lond). 2013. doi:10.1038/ijo.2013.172. Vgontzas AN, Fernandez-Mendoza J, Miksiewicz T, Kritikou I, Shaffer ML, Liao D, et al. Unveiling the longitudinal association between short sleep duration and the incidence of obesity: the Penn State cohort. Int J Obes (Lond). 2013. doi:10.​1038/​ijo.​2013.​172.
75.
go back to reference Lanfranchi PA, Pennestri MH, Fradette L, Dumont M, Morin CM, Montplaisir J. Nighttime blood pressure in normotensive subjects with chronic insomnia: implications for cardiovascular risk. Sleep. 2009;32:760–6.PubMed Lanfranchi PA, Pennestri MH, Fradette L, Dumont M, Morin CM, Montplaisir J. Nighttime blood pressure in normotensive subjects with chronic insomnia: implications for cardiovascular risk. Sleep. 2009;32:760–6.PubMed
76.••
go back to reference Spiegelhalder K, Fuchs L, Ladwig J, Kyle SD, Nissen C, Voderholzer U, et al. Heart rate and heart rate variability in subjectively reported insomnia. J Sleep Res. 2011;20:137–45. This study showed that impaired heart rate variability was present in insomniacs with objective short sleep duration.PubMedCrossRef Spiegelhalder K, Fuchs L, Ladwig J, Kyle SD, Nissen C, Voderholzer U, et al. Heart rate and heart rate variability in subjectively reported insomnia. J Sleep Res. 2011;20:137–45. This study showed that impaired heart rate variability was present in insomniacs with objective short sleep duration.PubMedCrossRef
77.
go back to reference De Zambotti M, Covassin N, De Min TG, Sarlo M, Stegagno L. Sleep onset and cardiovascular activity in primary insomnia. J Sleep Res. 2011;20:318–25.PubMedCrossRef De Zambotti M, Covassin N, De Min TG, Sarlo M, Stegagno L. Sleep onset and cardiovascular activity in primary insomnia. J Sleep Res. 2011;20:318–25.PubMedCrossRef
78.•
go back to reference Knutson KL, Van Cauter E, Zee P, Liu K, Lauderdale DS. Cross-sectional associations between measures of sleep and markers of glucose metabolism among subjects with and without diabetes: the Coronary Artery Risk Development in Young Adults (CARDIA) Sleep Study. Diabetes Care. 2011;34:1171–6. This cohort study showed that markers of glucose metabolism were poorest in insomniacs with objective short sleep duration.PubMedCrossRef Knutson KL, Van Cauter E, Zee P, Liu K, Lauderdale DS. Cross-sectional associations between measures of sleep and markers of glucose metabolism among subjects with and without diabetes: the Coronary Artery Risk Development in Young Adults (CARDIA) Sleep Study. Diabetes Care. 2011;34:1171–6. This cohort study showed that markers of glucose metabolism were poorest in insomniacs with objective short sleep duration.PubMedCrossRef
79.
80.••
go back to reference Fernandez-Mendoza J, Calhoun S, Bixler EO, Pejovic S, Karataraki M, Liao D, et al. Insomnia with objective short sleep duration is associated with deficits in neuropsychological performance: a general population study. Sleep. 2010;33:459–65. This cohort study showed an association of insomnia with objective short sleep duration with significant neurocognitive impairment.PubMed Fernandez-Mendoza J, Calhoun S, Bixler EO, Pejovic S, Karataraki M, Liao D, et al. Insomnia with objective short sleep duration is associated with deficits in neuropsychological performance: a general population study. Sleep. 2010;33:459–65. This cohort study showed an association of insomnia with objective short sleep duration with significant neurocognitive impairment.PubMed
81.••
go back to reference Edinger JD, Means MK, Krystal AS. Does physiological hyperarousal enhance error rates among patients with insomnia? Sleep. 2013;36:1179–86. This cohort study showed an association of insomnia with physiological hyperarousal with significant neurocognitive impairment.PubMed Edinger JD, Means MK, Krystal AS. Does physiological hyperarousal enhance error rates among patients with insomnia? Sleep. 2013;36:1179–86. This cohort study showed an association of insomnia with physiological hyperarousal with significant neurocognitive impairment.PubMed
82.
go back to reference Fortier-Brochu E, Beaulieu-Bonneau S, Ivers H, Morin CM. Insomnia and daytime cognitive performance: a meta-analysis. Sleep Med Rev. 2012;16:83–94.PubMedCrossRef Fortier-Brochu E, Beaulieu-Bonneau S, Ivers H, Morin CM. Insomnia and daytime cognitive performance: a meta-analysis. Sleep Med Rev. 2012;16:83–94.PubMedCrossRef
83.•
go back to reference Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U, et al. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord. 2011;135:10–9. This meta-analysis showed that insomnia is a significant predictor of incident depression. Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U, et al. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord. 2011;135:10–9. This meta-analysis showed that insomnia is a significant predictor of incident depression.
84.
go back to reference Morin CM, Bélanger L, LeBlanc M, Ivers H, Savard J, Espie CA, et al. The natural history of insomnia: a population-based 3-year longitudinal study. Arch Intern Med. 2009;169:447–53.PubMedCrossRef Morin CM, Bélanger L, LeBlanc M, Ivers H, Savard J, Espie CA, et al. The natural history of insomnia: a population-based 3-year longitudinal study. Arch Intern Med. 2009;169:447–53.PubMedCrossRef
85.•
go back to reference Vgontzas AN, Fernandez-Mendoza J, Bixler EO, Singareddy R, Shaffer ML, Calhoun SL, et al. Persistent insomnia: the role of objective short sleep duration and mental health. Sleep. 2012;35:61–8. This cohort study showed that objective short sleep duration and mental health problems predict the persistence of insomnia.PubMed Vgontzas AN, Fernandez-Mendoza J, Bixler EO, Singareddy R, Shaffer ML, Calhoun SL, et al. Persistent insomnia: the role of objective short sleep duration and mental health. Sleep. 2012;35:61–8. This cohort study showed that objective short sleep duration and mental health problems predict the persistence of insomnia.PubMed
86.
go back to reference Edinger JD, Means MK, Carney CE, Krystal AD. Psychomotor performance deficits and their relation to prior nights’ sleep among individuals with primary insomnia. Sleep. 2008;31:599–607.PubMed Edinger JD, Means MK, Carney CE, Krystal AD. Psychomotor performance deficits and their relation to prior nights’ sleep among individuals with primary insomnia. Sleep. 2008;31:599–607.PubMed
87.
go back to reference Fung MM, Peters K, Redline S, Ziegler MG, Ancoli-Israel S, Barrett-Connor E, et al. Decreased slow wave sleep increases risk of developing hypertension in elderly men. Hypertension. 2011;58:596–603.PubMedCrossRef Fung MM, Peters K, Redline S, Ziegler MG, Ancoli-Israel S, Barrett-Connor E, et al. Decreased slow wave sleep increases risk of developing hypertension in elderly men. Hypertension. 2011;58:596–603.PubMedCrossRef
88.
go back to reference Sánchez-Ortuño MM, Edinger JD, Means MK, Almirall D. Home is where sleep is: an ecological approach to test the validity of actigraphy for the assessment of insomnia. J Clin Sleep Med. 2010;6:21–9.PubMed Sánchez-Ortuño MM, Edinger JD, Means MK, Almirall D. Home is where sleep is: an ecological approach to test the validity of actigraphy for the assessment of insomnia. J Clin Sleep Med. 2010;6:21–9.PubMed
89.
go back to reference Deuschle M, Schmider J, Weber B, Standhardt H, Körner A, Lammers CH, et al. Pulse-dosing and conventional application of doxepin: effects on psychopathology and hypothalamus-pituitary-adrenal (HPA) system. J Clin Psychopharmacol. 1997;17:156–60.PubMedCrossRef Deuschle M, Schmider J, Weber B, Standhardt H, Körner A, Lammers CH, et al. Pulse-dosing and conventional application of doxepin: effects on psychopathology and hypothalamus-pituitary-adrenal (HPA) system. J Clin Psychopharmacol. 1997;17:156–60.PubMedCrossRef
90.
go back to reference Monteleone P. Effects of trazodone on plasma cortisol in normal subjects. A study with drug plasma levels. Neuropsychopharmacology. 1991;5:61–4.PubMed Monteleone P. Effects of trazodone on plasma cortisol in normal subjects. A study with drug plasma levels. Neuropsychopharmacology. 1991;5:61–4.PubMed
91.
go back to reference Edinger JD, Wohlgemuth WK, Radtke RA, Marsh GR, Quillian RE. Cognitive behavioral therapy for treatment of chronic primary insomnia: a randomized controlled trial. JAMA. 2001;285:1856–64.PubMedCrossRef Edinger JD, Wohlgemuth WK, Radtke RA, Marsh GR, Quillian RE. Cognitive behavioral therapy for treatment of chronic primary insomnia: a randomized controlled trial. JAMA. 2001;285:1856–64.PubMedCrossRef
92.
go back to reference Edinger JD, Fins AI, Glenn DM, Sullivan Jr RJ, Bastian LA, Marsh GR, et al. Insomnia and the eye of the beholder: are there clinical markers of objective sleep disturbances among adults with and without insomnia complaints? J Consult Clin Psychol. 2000;68:586–93.PubMedCrossRef Edinger JD, Fins AI, Glenn DM, Sullivan Jr RJ, Bastian LA, Marsh GR, et al. Insomnia and the eye of the beholder: are there clinical markers of objective sleep disturbances among adults with and without insomnia complaints? J Consult Clin Psychol. 2000;68:586–93.PubMedCrossRef
Metadata
Title
Insomnia and its Impact on Physical and Mental Health
Authors
Julio Fernandez-Mendoza
Alexandros N. Vgontzas
Publication date
01-12-2013
Publisher
Springer US
Published in
Current Psychiatry Reports / Issue 12/2013
Print ISSN: 1523-3812
Electronic ISSN: 1535-1645
DOI
https://doi.org/10.1007/s11920-013-0418-8

Other articles of this Issue 12/2013

Current Psychiatry Reports 12/2013 Go to the issue

Schizophrenia and Other Psychotic Disorders (SJ Siegel, Section Editor)

Use of Antipsychotic Medications in Pediatric Populations: What do the Data Say?

Personality Disorders (C Schmahl, Section Editor)

Antisocial Personality Disorder: A Current Review